SUMMARY The electrophysiological effects of intravenous sotalol hydrochloride (0-4 mg/kg) were assessed in 24 patients, including 13 with the Wolff-Parkinson-White syndrome, undergoing routine electrophysiological study. Fifteen to 30 minutes after sotalol administration there was a significant increase in sinus cycle length and in sinus node recovery time. There was a small increase in the AH interval, but the HV interval was unchanged. The QT and JT intervals, measured during sinus rhythm, were both increased. The atrial, ventricular, and atrioventricular nodal effective refractory periods were all prolonged, as was the atrioventricular nodal functional refractory period. In 13 patients with ventricular pre-excitation there was an increase of the accessory pathway anterograde and retrograde effective refractory periods. In 12 of these 13 sotalol was given during atrioventricular re-entrant tachycardia, resulting in termination in five. Tachycardia cycle length increased in all patients, with the major effect being in the atrioventricular direction. Though some of the effects seen in these patients are consistent with the beta adrenergic antagonist properties of sotalol, the effect on atrial, ventricular, and accessory pathway effective refractory periods and on ventricular repolarisation is not typical of that observed with other beta blockers but may be the result of lengthening of the action potential duration. These findings suggest that sotalol may be a more versatile antiarrhythmic agent than other beta receptor antagonists. Sotalol hydrochloride was initially described as a pure beta adrenergic antagonist with class II antiarrhythmic action, but lacking cardioselectivity, intrinsic sympathomimetic effect, or local anaesthetic properties.1-3 Subsequent animal investigations have shown that sotalol also causes a large increase in the action potential duration, similar to that seen with amiodarone.45 These 
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Results
The dose of sotalol used varied from 18 to 32 (mean 24) mg. All measurements are written as the mean value ± one standard deviation from the mean.
SINUS NODE FUNCTION
Sinus cycle length increased in all patients from 739±107 to 869±109 ms (p<0.001). Sinus node recovery time, measured only in group B patients, increased from 1084±302 to 1270±301 ms (p<0-01).
CONDUCTION
There was a small increase in the PA interval from 43±13 to 45± 13 ms (p<0-02), and a larger increase in the AH interval from 82±28 to 94±32 ms (p<0-001). The AH interval could not be measured in one group A patient (case 1) because of the degree of preexcitation. In the patients without pre-excitation (group B) there was no significant change in the HV interval (44± 12 to 45± 13 ms). In these patients there was no significant increase in the QRS duration measured during sinus rhythm (102±20 to 106±19 ms) or during constant rate atrial pacing (104±19 to 106±20 ms). The QT interval increased from 401±45 to 427±38 ms (p<0.01) (Fig. la) , and the paced QT interval from 388±43 to 400±37 ms (p<0.01) (Fig.  lb) , but the QTc was not significantly increased (450±48 to 455±46 ms) (Fig. la) . The JT interval increased from 300±44 to 321±35 ms (p<0.02) (Fig.  la) and the paced JT interval from 284±37 to 294±31 ms (p<0.05) (Fig. lb) .
REFRACTORINESS
The atrial effective refractory period increased from 216±38 to 233±40 ms (p<0-01), and effective refractory period of the ventricle from 231±30 to 242±31 ms (p<0.01). The effective refractory period of the atrioventricular node was limited by atrial refractoriness or obscured by accessory pathway conduction in 12 patients. In the remaining 12 there was an increase from 294±87 to 338±90 ms (p<0-001). The functional refractory period of the atrioventricular node was limited by atrial refractoriness in 11 patients and in the remaining 13 toriness in three patients. In the other 10 patients, complete accessory pathway block occurred in two (effective refractory period of the accessory pathway in the retrograde direction >600 ms), refractoriness increased in six and decreased in two, an overall change from 296+40 to 371+ 139 ms (p<0.05).
TACHYCARDIA INTERVALS
Sotalol was given during tachycardia in 12 out of the 13 group A patients, terminating it in five. An example of anterograde termination is shown (Fig. 2) . The mean total cycle length increased from 355+64 to 413+54 ms (p<0.001) (Fig. 3a) . In this study, and that briefly reported by Echt and colleagues,30 sotalol significantly prolonged the QT interval measured during sinus rhythm. The QT interval assessed during identical rate atrial pacing was also increased by sotalol, but this has not been the case with propranolol.32 The prolongation of the QT was confined to the JT interval as the QRS complex width did not prolong. In the present study the QTc lengthened very slightly but this change was not significant. Bazett's correction of the QT interval (QTc) was formulated to allow for physiological variation in heart rate, and is of uncertain value in pharmacological studies. Neuvonenet al. ,33however, have demonstrated an approximately linear relation between QTc prolongation and serum sotalol concentration. In addition, a number of investigators have shown dramatic increases of the QT and QTc intervals associated with sotalol intoxication and in several instances this has been associated with ventricular arrhythmias (torsade de pointes). [34] [35] [36] The effects of sotalol on the ventricular and accessory pathway effective refractory periods and on the QT and JT intervals are not typical of beta adrenergic antagonists, but are seen with other drugs which prolong the action potential and are consistent with additional class III action. Similar electrophysiological and proarrhythmic effects have been found with the prototype class III agent, amiodarone.37-39
The efficacy of sotalol, however, when given during established atrioventricular re-entrant tachycardia in this study is disappointing. Though tachycardia slowed in all patients it terminated in only five, with termination occurring in the anterograde direction. Furthermore, the tachycardia atrioventricular interval prolonged to a greater extent than the ventriculoatrial interval, suggesting a predominantly atrioventricular nodal effect.
Sotalol shows the electrophysiological effects of a class III antiarrhythmic agent as well as those of a competitive beta receptor antagonist, but the relevance of these findings to clinical practice requires further evaluation. 
